Cañales, Renelia .

HRN: 01-62-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFTAZIDIME 1GM (VIAL)
01/03/2023
01/09/2023
IV
1g
Q8
CAP-MR, T/C PTB Relapse
Waiting Final Action 
01/05/2023
METRONIDAZOLE 500MG (TAB)
01/05/2023
01/11/2023
ORAL
500mg
TID
H Pylori Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: